Houston, TX – According to filings with the U.S. Securities and Exchange Commission, Procyrion is raising $30 Million in a new round of investment. Sources indicate as part of senior management President and Chief Executive Officer, Eric Fain played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Procyrion

Procyrion is  developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.

To learn more about Procyrion, visit http://www.procyrion.com

Contact:
Eric Fain, President and Chief Executive Officer
713-579-9227
eric@procyrion.com
https://www.linkedin.com/in/eric-fain-149408b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved